AirCurve™ 11
A next-level therapy experience
Resmed's next-generation bilevel series, designed to help patients start, acclimate to and adhere to therapy more easily, taking therapy to the next level.


AirCurve 11 ASV
Adaptive servo-ventilation* bilevel device
Delivers adaptive pressure support designed to stabilise breathing and personalise therapy for patients with central sleep apnea (CSA), obstructive and mixed apneas, and periodic breathing.
*ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2−4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnea.
Bilevel therapy, redefined
Bilevel therapy delivers two levels of pressure —inspiratory (IPAP) and expiratory (EPAP) — for patients who need additional pressure support.
AirCurve™ 11 brings a new era of bilevel therapy with the Air11™ connected ecosystem and features to simplify therapy and connected features to simplify therapy and support more personalised care for patients with complex needs.
83%
of patients reported that they felt confident in using AirCurve 11 for ongoing PAP therapy.1
AirCurve 11 highlights
Sleek, modern design
Helps reduce the stigma of having a PAP device on the nightstand.
Easy-to-use touchscreen
Makes navigating settings simple and intuitive.
Over-the-air updates
Uses cellular technology^ to deliver the latest software updates automatically to Air11 device, so users can benefit from future Resmed technology.
Built-in cellular^ and Bluetooth®
Cellular connectivity^ securely and automatically transmits data to the cloud, giving you seamless access in AirView™ while allowing patients to track their therapy progress in myAir™. Bluetooth connectivity to myAir assists with device setup for a more interactive therapy experience.
Care Check-In
Is a built-in coaching program that encourages users to regularly self report on therapy progress, and provides you with access to subjective user insights via AirView™#.
Personal Therapy Assistant
Featured in the Resmed myAir™^^ patient engagement app, Personal Therapy Assistant helps users start therapy with instructions and Test Drive, our acclimation tool. confidence through interactive, voice-guided video setup.
^Cellular connectivity depends on network availability.
#Care Check-In data is available in AirView upon customer consent.
^^myAir requires cellular connectivity.
The Air11 ecosystem
The Air11 connected ecosystem is designed to provide patients with an easier start to therapy and a more successful acclimatisation period.2
Remote support features help guide your patients from the outset, while clinical insights give you a fuller picture of how they’re doing. The connected ecosystem helps you troubleshoot any early issues and target intervention where it’s needed most.
Using coaching and the ability to track and view nightly sleep data, myAir and AirView together have been found to improve patient compliance from 70% to 87%.3
myAir™
The online coaching and support program and app for patients that’s like having their own personal sleep coach,† enhanced with support for bilevel patients.
AirView™
A secure, cloud-based system that helps providers manage patients, enabling an informed pathway to optimal care.
Masks
Resmed masks are designed to provide an optimised therapy experience with Air11 devices and myAir.
AirCurve™ 11
VAuto and ASV* bilevel devices feature the trusted algorithms used in AirCurve 10 devices.
Personal Therapy Assistant
One of the many features in myAir that offers interactive, voice-guided instructions and videos to help guide patients through equipment setup and get comfortable with therapy.**
Care Check-In
Care Check-In questions specific to bilevel therapy goals and acclimation obstacles providing support to patients and insights to healthcare professionals.‡**
91% of CPAP patients who completed all Care Check-In checks achieved compliance for AirSenseTM 11.4
References
- Resmed online survey of U.S. patients registered with myAir, conducted July-August 2022 (total N=97; question-level N=38-95). Data on file: eLB1708-37.
- Resmed Air11 survey of 146 patients, conducted from 28 June to 29 July 2021. Q19: 62% of patients reported that they felt confident about starting PAP therapy after being set up on AirSense 11, N=119 respondents. Q10: 63% of patients said that PTA gave them confidence to set up their PAP machine correctly, N=49 respondents. Data on file; ID A5043180.
- Malhotra et al. "Patient Engagement Using New Technology to Improve Adherence to Positive Airway Pressure Therapy: A Retrospective Analysis." Chest. 2018 Apr;153(4):843-850. doi: 10.1016/j.chest.2017.11.005.
- Resmed analysis of Care Check-In data of patients using a Resmed AirSense device and who have at least 90 days of therapy data. Data collected April 16, 2021 - May 12, 2022. n=12,409. Actual results may vary.
* ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2−4) with reduced left ventricular ejection fraction (LVEF ≤ 45%)
† Coaching entails personalised feedback to encourage continuation of therapy. This is not a healthcare service and is not performed by licensed healthcare providers. Patients are encouraged to speak with their treating clinicians for any clinical symptoms or medical conditions.
‡ Patient consent required for Care Check-In.
** Some features of myAir are only available in the myAir app and with Air11 devices.
ALWAYS READ THE LABEL AND FOLLOW THE INSTRUCTIONS FOR USE. You or your customers should speak to their doctor about symptoms and whether a PAP device is suitable.